price
RE
NASDAQ · REPL
Replimune Group, Inc.
Healthcare · Biotechnology
$14.45
Down-$1.21 (-8.37%)
Updated Sep 11, 2026, 12:40 AM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 774.6M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $16.33
- Volume
- 1.07M
- Avg. volume
- 5.08M
Price performance
REPL price history
1M range · 0 trading sessions · Daily adjusted prices
REPL does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest REPL news
The latest Smart Investors Daily articles mentioning REPL.
Stock researchResearch & News · Analysis
Loading stock research…